King's College London

Research portal

Apomorphine infusion for improving sleep in Parkinson's disease

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Pages (from-to)395-398
Number of pages4
JournalThe Lancet Neurology
Issue number5
Published1 May 2022

Bibliographical note

Funding Information: KRC declares grant support from Bial, Britannia, AbbVie, UCB, GKC, EU Horizon 2020, Parkinson's UK, NIHR, Parkinson's Foundation, Wellcome Trust, Kirby Laing Foundation, and MRC; has served as an advisory board member for, received consultancy and speaking fees from, and declares travel support from, AbbVie, UCB, GKC, Bial, Cynapsus, Lobsor, Stada, Zambon, Profile Pharma, Synovion, Roche, Theravance, Scion, Britannia, Acadia, 4D Pharma, and Medtronic; reports royalties or licenses from Oxford and Cambridge publishers (books) and the Mapi Institute (KPPS, PDSS 2); and has received payment for expert testimony from GMC. VL declares honoraria for speaking and manuscript writing from Britannia.

King's Authors

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454